Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record was updated with new arm descriptions, dosing details, and eligibility language, and an IPD sharing plan was added; a 'Results Posted' notice was also included to reflect recent outcomes.SummaryDifference3%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedMerck sponsor details and IPD sharing resources were added, along with related informational links. The update expands the page with governance and data-sharing context for the trial.SummaryDifference82%

- Check33 days agoChange DetectedThe results status is updated to 'Results Submitted,' replacing the previous 'No Results Posted,' and the page revision has been updated to v3.6.5 (replacing v3.6.4).SummaryDifference0.1%

- Check40 days agoChange DetectedAdded related topic tags for Melanoma and MedlinePlus Genetics to the page. These additions enhance discoverability and connect users to broader melanoma information and genetic resources without changing the study content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays Revision: v3.6.4, indicating a newer version of the content, and the items Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.3 were removed from the page.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded related topics entries for Melanoma and MedlinePlus Genetics to the study page's related topics section. This enhances navigational context by providing quick access to melanoma information and genetics resources.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.